Concerto HealthAI

By Dave Muoio 03:26 pm March 5, 2020
SymphonyAI Group, a collection of private B2B artificial intelligence companies spanning multiple sectors, announced yesterday that it has acquired TeraRecon, the maker of products for medical-image post-processing and other related products. As the group’s seventh portfolio company, TeraRecon will continue building out its radiology, cardiology and vascular-surgery AI-imaging support. However,...
By Dave Muoio 03:39 pm January 15, 2020
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, has closed $150 million in aggregate Series B financing. Declaration Partners headed the investments, which also featured Maverick Ventures, AllianceBernstein PCI and SymphonyAI Group. Concerto boasts 90% year-over-year revenue growth for its business, and paired the funding...
By Dave Muoio 12:00 pm April 9, 2019
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, Concerto announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology...
By Dave Muoio 01:13 pm March 29, 2019
Bristol-Myers Squibb’s research efforts will be getting an artificial intelligence boost thanks to a new multi-year deal signed by the pharmaceutical company and Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses. According to the announcement, Concerto’s eurekaHealth tool will “accelerate insights through novel health economic...